🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety, efficacy and pharmacokinetics of nilotinib over tim...
Status
Completed
Location
Loma Linda University Cancer Center
Start Date
2013-08-20
Trial ID
NCT01844765
Treatments Being Tested
The purpose of this study is to determine the efficacy of imatinib mesylate...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2007-12
Trial ID
NCT00677092
Treatments Being Tested
This phase II trial studies the side effects and how well letrozole and ima...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2003-10-03
Trial ID
NCT00338728
Treatments Being Tested
This is a non-randomized, prospective, single-group longitudinal study. The...
Status
Completed
Location
Helen Diller Family Comprehensive Cancer Center University of California
Start Date
2014-12-18
Trial ID
NCT02269267
The objectives of this study are to describe patient demographics, clinical...
Status
Completed
Location
Pfizer
Start Date
2020-11-18
Trial ID
NCT05286528
This phase II trial studies how well giving imatinib mesylate together with...
Status
Completed
Location
Blood and Marrow Transplant Group of Georgia
Start Date
2002-04
Trial ID
NCT00039377
Treatments Being Tested
This study will investigate the efficacy and tolerability of a short (6 mon...
Status
Unknown
Location
Medical University Innsbruck
Start Date
2004-01
Trial ID
NCT00327262
Treatments Being Tested
Retrospective correlation of clinical outcomes data with mutational status ...
Status
Completed
Location
City of Hope
Start Date
2011-10
Trial ID
NCT01459757
Treatments Being Tested
The purpose of this multicenter, single-arm, Simon two-stage, phase II tria...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-10
Trial ID
NCT00510354
Treatments Being Tested
Phase II trial to study the effectiveness of neoadjuvant and adjuvant imati...
Status
Completed
Location
Radiation Therapy Oncology Group
Start Date
2002-03-31
Trial ID
NCT00028002
Treatments Being Tested